Relapsed Acute Myeloid Leukemia With Isolated Conjugated Hyperbilirubinemia Secondary to High-Dose Cytarabine Therapy

被引：0
|
作者：
Akpara, Ugochukwu [1 ]
Choi, Anthony J. [2 ]
Wan, David [3 ]
机构：
[1] New York Presbyterian Weill Cornell Med Ctr, Brooklyn, NY USA
[2] New York Presbyterian Weill Cornell Med Ctr, New York, NY USA
[3] Cornell Univ, Weill Cornell Med Coll, New York, NY 10021 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2020年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S2562
引用
收藏
页码：S1348 / S1348
页数：1
相关论文
共 50 条
  • [41] Idarubicin, high-dose cytarabine and etoposide for induction of remission in acute myeloid leukemia.
    Singhal, S
    Powles, R
    Treleaven, J
    Horton, C
    Hamblin, M
    Zomas, A
    Prendiville, J
    Saso, R
    Mackay, H
    Milan, S
    Mehta, J
    BLOOD, 1995, 86 (10) : 2039 - 2039
  • [42] Toxicity and outcome of adults with acute myeloid leukemia receiving consolidation with high-dose cytarabine
    Lopes, Lais Moreira
    Nucci, Marcio
    Portugal, Rodrigo Doyle
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2024, 46 (04) : 397 - 401
  • [43] Outcome of Patients with Acute Myeloid Leukemia Treated with Salvage High-Dose Cytarabine Monotherapy
    Canaani, Jonathan
    Luskin, Marlise R.
    Loren, Alison
    Timlin, Colleen
    Mangan, James
    Hexner, Elizabeth O.
    Frey, Noelle V.
    Porter, David L.
    Stadtmauer, Edward A.
    Luger, Selina
    BLOOD, 2015, 126 (23)
  • [44] Incidence of infection in patients with acute myeloid leukemia receiving high-dose cytarabine consolidation
    Mcclellan, Kristen
    Messina, Julia
    Saullo, Jennifer
    Huggins, Jonathan
    ANNALS OF HEMATOLOGY, 2024, 103 (12) : 5351 - 5358
  • [45] Takotsubo Cardiomyopathy after Systemic Consolidation Therapy with High-Dose Intravenous Cytarabine in a Patient with Acute Myeloid Leukemia
    Baumann, Stefan
    Huseynov, Aydin
    Goranova, Diana
    Faust, Melanie
    Behnes, Michael
    Nolte, Florian
    Heidenreich, Daniela
    Hofmann, Wolf-Karsten
    Borggrefe, Martin
    Akin, Ibrahim
    Klein, Stefan
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 (09) : 487 - 490
  • [46] IDARUBICIN, HIGH-DOSE CYTARABINE AND ETOPOSIDE FOR REMISSION INDUCTION IN THERAPY-RELATED ACUTE MYELOID-LEUKEMIA
    PHILPOTT, N
    MEHTA, J
    TRELEAVEN, J
    POWLES, R
    LEUKEMIA & LYMPHOMA, 1994, 15 (1-2) : 127 - 130
  • [47] Does high-dose cytarabine cause cumulative toxicity in patients undergoing consolidation therapy for acute myeloid leukemia?
    Wiernik, Andres
    Sperr, Wolfgang R.
    Weisdorf, Daniel
    Valent, Peter
    Ustun, Celalettin
    AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (06) : 533 - 534
  • [48] A Phase I Study of CPI-613 in Combination with High-Dose Cytarabine and Mitoxantrone for Relapsed or Refractory Acute Myeloid Leukemia
    Pardee, Timothy S.
    Anderson, Rebecca G.
    Pladna, Kristin M.
    Isom, Scott
    Ghiraldeli, Lais P.
    Miller, Lance D.
    Chou, Jeff W.
    Jin, Guangxu
    Zhang, Wei
    Ellis, Leslie R.
    Berenzon, Dmitriy
    Howard, Dianna S.
    Hurd, David D.
    Manuel, Megan
    Dralle, Sarah
    Lyerly, Susan
    Powell, Bayard L.
    CLINICAL CANCER RESEARCH, 2018, 24 (09) : 2060 - 2073
  • [49] A new combination of carboplatin, high-dose cytarabine and cross-over mitoxantrone or idarubicin for refractory and relapsed acute myeloid leukemia
    Bassan, R
    Lerede, T
    Buelli, M
    Borleri, G
    Bellavita, P
    Rambaldi, A
    Barbul, T
    HAEMATOLOGICA, 1998, 83 (05) : 422 - 427
  • [50] High-dose cytarabine-based therapy in adults with acute lymphoblastic leukemia
    Feldman, EJ
    LEUKEMIA RESEARCH, 2000, 24 (03) : 189 - 191
12345